Frankfurt - Delayed Quote EUR
Galapagos NV (GXE.F)
24.76
+0.02
+(0.08%)
At close: June 13 at 9:46:58 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-236,199
-320,026
-405,970
-500,544
-503,827
Investing Cash Flow
275,677
220,597
71,186
-1,245,514
541,238
Financing Cash Flow
-4,767
-4,924
-5,001
-1,487
-3,876
End Cash Position
108,083
64,239
166,810
508,117
2,233,368
Capital Expenditure
-81,098
-82,110
-19,273
-36,947
-57,879
Issuance of Capital Stock
--
--
--
--
0
Repayment of Debt
-4,767
-4,924
-6,771
-8,182
-7,190
Free Cash Flow
-317,297
-402,136
-425,243
-537,491
-561,706
12/31/2021 - 6/28/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
AB3A.MU Sarepta Therapeutics Inc
31.82
-1.18%
ITRX inTerra Resources Corp
0.0240
0.00%
8QQ.BE AbCellera Biologics Inc
2.5800
-6.99%
GENSY Genus plc
24.34
0.00%
T3X.BE Telix Pharmaceuticals Ltd
13.93
-5.63%
AYJ.HA Valneva SE
2.6180
-4.10%
ONCIN.OL Oncoinvent ASA
1.8500
-8.64%
300759.SZ Pharmaron Beijing Co., Ltd.
24.84
-2.47%
BCX.WA Bioceltix S.A.
111.20
-2.46%